JESSICA WATSON: Open Payments
NPI 1740951078 · AVON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$243 in 12 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $171 · 2025 $243
Food & beverage: $243
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| ABBVIE INC. | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Corium, LLC | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $15 |
Products named: Auvelity, CAPLYTA, REXULTI, VRAYLAR, SPRAVATO, Azstarys, Qelbree.
Industry payments across IN — which companies pay providers there.
